<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39444797</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2749-9642</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Medical review (2021)</Title><ISOAbbreviation>Med Rev (2021)</ISOAbbreviation></Journal><ArticleTitle>Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID.</ArticleTitle><Pagination><StartPage>367</StartPage><EndPage>383</EndPage><MedlinePgn>367-383</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/mr-2024-0013</ELocationID><Abstract><AbstractText>COVID-19 posed a major challenge to the healthcare system and resources worldwide. The popularization of vaccines and the adoption of numerous prevention and control measures enabled the gradual end of the COVID-19 pandemic. However, successive occurrence of autoimmune diseases in patients with COVID-19 cannot be overlooked. Long COVID has been the major focus of research due to the long duration of different symptoms and the variety of systems involved. Autoimmunity may play a crucial role in the pathogenesis of long COVID. Here, we reviewed several autoimmune disorders occurring after COVID-19 infection and the pathogenesis of long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 the author(s), published by De Gruyter, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0008-8340-2836</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Shunlai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengfei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Guangyan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiangmei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Haihe Laboratory of Cell Ecosystem, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qinggang</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-8788-6670</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Rev (2021)</MedlineTA><NlmUniqueID>9918383871606676</NlmUniqueID><ISSNLinking>2749-9642</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>Competing interests: The authors state no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39444797</ArticleId><ArticleId IdType="pmc">PMC11495526</ArticleId><ArticleId IdType="doi">10.1515/mr-2024-0013</ArticleId><ArticleId IdType="pii">mr-2024-0013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  . WHO coronavirus (COVID-19) dashboard.  [August 22, 2023]. https://covid19.who.int n.d. Available from: Accessed.</Citation></Reference><Reference><Citation>WHO  . WHO director-general&#x2019;s opening remarks at the media briefing&#xa0;&#x2013; 5 May 2023.  [August 22, 2023]. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023 n.d. Available from: Accessed.</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long Covid. Soc Sci Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58:297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: let patients help define long-lasting COVID symptoms. Nature. 2020;586:170. doi: 10.1038/d41586-020-02796-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedgley R, Winer-Jones J, Bonafede M. Long COVID incidence in a large US ambulatory electronic health record system. Am J Epidemiol. 2023;192:1350&#x2013;7. doi: 10.1093/aje/kwad095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwad095</ArticleId><ArticleId IdType="pubmed">37073410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Mills NL, Winter AJ, Black C, et al. Natural history of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14:3504. doi: 10.1038/s41467-023-39193-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39193-y</ArticleId><ArticleId IdType="pmc">PMC10263377</ArticleId><ArticleId IdType="pubmed">37311808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonometti R, Sacchi MC, Stobbione P, Lauritano EC, Tamiazzo S, Marchegiani A, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020;24:9695&#x2013;7. doi: 10.26355/eurrev_202009_23060.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202009_23060</ArticleId><ArticleId IdType="pubmed">33015814</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020;173:1027&#x2013;8. doi: 10.7326/l20-0845.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/l20-0845</ArticleId><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris A, Mushref MA. Graves&#x2019; thyrotoxicosis following SARS-CoV-2 infection. AACE Clin Case Rep. 2021;7:14&#x2013;6. doi: 10.1016/j.aace.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7834282</ArticleId><ArticleId IdType="pubmed">33521256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13:1077&#x2013;86. doi: 10.1111/cts.12805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12805</ArticleId><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou LQ, Hu ZW, Zhang SQ, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762&#x2013;78. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J. 2023;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370:1227&#x2013;30. doi: 10.1126/science.abd7728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7728</ArticleId><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020;5:eabe0367. doi: 10.1126/sciimmunol.abe0367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe0367</ArticleId><ArticleId IdType="pmc">PMC7857394</ArticleId><ArticleId IdType="pubmed">33033172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertin D, Kaphan E, Weber S, Babacci B, Arcani R, Faucher B, et al. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome. Int J Infect Dis. 2021;113:23&#x2013;5. doi: 10.1016/j.ijid.2021.09.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.079</ArticleId><ArticleId IdType="pmc">PMC8487460</ArticleId><ArticleId IdType="pubmed">34614444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023;74:339&#x2013;52. doi: 10.1146/annurev-med-043021-032611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-032611</ArticleId><ArticleId IdType="pubmed">35804480</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primer. 2020;6:7. doi: 10.1038/s41572-019-0141-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0141-9</ArticleId><ArticleId IdType="pubmed">31974366</ArticleId></ArticleIdList></Reference><Reference><Citation>Vista ES, Weisman MH, Ishimori ML, Chen H, Bourn RL, Bruneret BF, et al. Strong viral associations with SLE among filipinos. Lupus Sci Med. 2017;4:e000214. doi: 10.1136/lupus-2017-000214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2017-000214</ArticleId><ArticleId IdType="pmc">PMC5704743</ArticleId><ArticleId IdType="pubmed">29214036</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal Y, Dahan S, Calabr&#xf2; M, Kanduc D, Shoenfeld Y. HPV and systemic lupus erythematosus: a mosaic of potential cross reactions. Immunol Res. 2017;65:564&#x2013;71. doi: 10.1007/s12026-016-8890-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8890-y</ArticleId><ArticleId IdType="pubmed">28111707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol. 1999;14:73&#x2013;7. doi: 10.1016/s1386-6532(99)00038-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1386-6532(99)00038-4</ArticleId><ArticleId IdType="pubmed">10548133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazzi B, Fine D, Geetha D, Chung M, Trujillo MM, Timlin H. New-onset lupus nephritis associated with COVID-19 infection. Lupus. 2022;31:1007&#x2013;11. doi: 10.1177/09612033221098571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221098571</ArticleId><ArticleId IdType="pmc">PMC9066225</ArticleId><ArticleId IdType="pubmed">35485455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran L, Dontaraju VS, Troyer J, Sahota J. New onset systemic lupus erythematosus after COVID-19 infection: a case report. AME Case Rep. 2022;6:14. doi: 10.21037/acr-21-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acr-21-55</ArticleId><ArticleId IdType="pmc">PMC9010314</ArticleId><ArticleId IdType="pubmed">35475008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos AE, Saavedra-Salinas M&#xc1;. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. Rheumatol Int. 2021;41:799&#x2013;809. doi: 10.1007/s00296-021-04794-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04794-7</ArticleId><ArticleId IdType="pmc">PMC7861004</ArticleId><ArticleId IdType="pubmed">33543338</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso EM, Hundal J, Feterman D, Magaldi J. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol. 2020;39:2811&#x2013;5. doi: 10.1007/s10067-020-05310-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05310-1</ArticleId><ArticleId IdType="pmc">PMC7384868</ArticleId><ArticleId IdType="pubmed">32720260</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani B, Moeini Taba SM, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep. 2021;15:29. doi: 10.1186/s13256-020-02582-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-020-02582-8</ArticleId><ArticleId IdType="pmc">PMC7832415</ArticleId><ArticleId IdType="pubmed">33494816</ArticleId></ArticleIdList></Reference><Reference><Citation>Satorul K, Ibrahiml B, Dominickl S, Katherine X, Jonathan B, Yonatan P, et al. Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol. 2020;31:1959&#x2013;68. doi: 10.1681/asn.2020060802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2020060802</ArticleId><ArticleId IdType="pmc">PMC7461665</ArticleId><ArticleId IdType="pubmed">32680910</ArticleId></ArticleIdList></Reference><Reference><Citation>Slimani Y, Abbassi R, El Fatoiki FZ, Barrou L, Chiheb S. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2021;93:1184&#x2013;7. doi: 10.1002/jmv.26513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26513</ArticleId><ArticleId IdType="pubmed">32926434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hali F, Jabri H, Chiheb S, Hafiani Y, Nsiri A. A concomitant diagnosis of COVID&#x2010;19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: a new case report. Int J Dermatol. 2021;60:1030&#x2013;1. doi: 10.1111/ijd.15592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15592</ArticleId><ArticleId IdType="pmc">PMC8251349</ArticleId><ArticleId IdType="pubmed">33864388</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et al. Extrafollicular B&#xa0;cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21:1506&#x2013;16. doi: 10.1038/s41590-020-00814-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang XQ, et al. Distinct effector B&#xa0;cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018;49:725&#x2013;39.e6. doi: 10.1016/j.immuni.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao ZW, Wang X, Lin F, Dong K. The correlation between SARS-CoV-2 infection and rheumatic disease. Autoimmun Rev. 2020;19:102557. doi: 10.1016/j.autrev.2020.102557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102557</ArticleId><ArticleId IdType="pmc">PMC7194066</ArticleId><ArticleId IdType="pubmed">32371101</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejazian SS, Hejazian SM, Farnood F, Azar SA. Dysregulation of immunity in COVID-19 and SLE. Inflammopharmacology. 2022;30:1517&#x2013;31. doi: 10.1007/s10787-022-01047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01047-2</ArticleId><ArticleId IdType="pmc">PMC9417079</ArticleId><ArticleId IdType="pubmed">36028612</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O&#x2019;Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15:87&#x2013;103. doi: 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L. The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci. 2011;116:227&#x2013;37. doi: 10.3109/03009734.2011.624649.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009734.2011.624649</ArticleId><ArticleId IdType="pmc">PMC3207297</ArticleId><ArticleId IdType="pubmed">22066971</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M&#xf8;ller R, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036&#x2013;45.e9. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Orlova E, Sozaeva L, L&#xe9;vy R, James A, Schmittet MM, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021;218:e20210554. doi: 10.1084/jem.20210554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210554</ArticleId><ArticleId IdType="pmc">PMC8077172</ArticleId><ArticleId IdType="pubmed">33890986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20:585&#x2013;6. doi: 10.1038/s41577-020-00429-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC8824445</ArticleId><ArticleId IdType="pubmed">32788708</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM, et al. Myasthenia gravis. Nat Rev Dis Primer. 2019;5:30. doi: 10.1038/s41572-019-0079-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0079-y</ArticleId><ArticleId IdType="pubmed">31048702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. J Neurol. 2018;265:1251&#x2013;8. doi: 10.1007/s00415-018-8751-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8751-9</ArticleId><ArticleId IdType="pubmed">29372387</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber M, Rogozinski S, Puppe W, Framme C, H&#xf6;glinger G, Hufendiek K, et al. Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol. 2020;11:576153. doi: 10.3389/fneur.2020.576153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.576153</ArticleId><ArticleId IdType="pmc">PMC7573137</ArticleId><ArticleId IdType="pubmed">33123081</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez &#xc1;IP, Cuervo CS, Men&#xe9;ndez SF. Infecci&#xf3;n por SARS-CoV-2 asociada a diplop&#xed;a y anticuerpos antirreceptor de acetilcolina. Neurologia. 2020;35:264&#x2013;5. doi: 10.1016/j.nrl.2020.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7165292</ArticleId><ArticleId IdType="pubmed">32364121</ArticleId></ArticleIdList></Reference><Reference><Citation>Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Sette MD. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021;28:3537&#x2013;9. doi: 10.1111/ene.14721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14721</ArticleId><ArticleId IdType="pmc">PMC8014563</ArticleId><ArticleId IdType="pubmed">33421278</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody&#x2013;associated myasthenia gravis with SARS-CoV-2 infection: a case report. Ann Intern Med. 2021;174:872&#x2013;3. doi: 10.7326/l20-1298.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/l20-1298</ArticleId><ArticleId IdType="pmc">PMC7808439</ArticleId><ArticleId IdType="pubmed">33428437</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy YM, Osman S, Murthy JMK. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental? BMJ Case Rep. 2021;14:e244146. doi: 10.1136/bcr-2021-244146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244146</ArticleId><ArticleId IdType="pmc">PMC8296802</ArticleId><ArticleId IdType="pubmed">34290032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2021;268:2690&#x2013;6. doi: 10.1007/s00415-020-10263-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10263-1</ArticleId><ArticleId IdType="pmc">PMC7549728</ArticleId><ArticleId IdType="pubmed">33047223</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi N, Okhovat AA, Ziaadini B, Ashtiani BH, Nafissi S, Fatehi F. Myasthenia gravis associated with novel coronavirus 2019 infection: a report of three cases. Clin Neurol Neurosurg. 2021;208:106834. doi: 10.1016/j.clineuro.2021.106834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106834</ArticleId><ArticleId IdType="pmc">PMC8299214</ArticleId><ArticleId IdType="pubmed">34329810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandarwar A, Jadhav S, Tandur A, Dhimole N, Wagh A, Bhondve S. Management of thymomatous myasthenia gravis&#xa0;&#x2013; case report of a rare Covid19 infection sequelae. Int J Surg Case Rep. 2021;81:105771. doi: 10.1016/j.ijscr.2021.105771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijscr.2021.105771</ArticleId><ArticleId IdType="pmc">PMC7954768</ArticleId><ArticleId IdType="pubmed">33744800</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf5;gi K, Sabre L, Rosental M, Leheste AR, Vilisaar J. New onset generalized myasthenia gravis evolving following SARS-CoV-2 infection. COVID. 2022;2:464&#x2013;71. doi: 10.3390/covid2040033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2040033</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri A, Davoodi L, Soleymani E, Ahmadi N. New-onset myasthenia gravis after novel coronavirus 2019 infection. Respirol Case Rep. 2022;10:e0978. doi: 10.1002/rcr2.978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcr2.978</ArticleId><ArticleId IdType="pmc">PMC9125167</ArticleId><ArticleId IdType="pubmed">35620352</ArticleId></ArticleIdList></Reference><Reference><Citation>Tereshko Y, Gigli GL, Pez S, Pellegrin AD, Valente M. New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review. J Neurol. 2023;270:601&#x2013;9. doi: 10.1007/s00415-022-11472-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11472-6</ArticleId><ArticleId IdType="pmc">PMC9645742</ArticleId><ArticleId IdType="pubmed">36352330</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues CL, de Freitas HC, Lima PRO, de Oliveira Junior PH, Fernandes JMA, D&#x2019;Almeida JAC, et al. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review. Neurol Sci. 2022;43:2271&#x2013;6. doi: 10.1007/s10072-021-05823-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05823-w</ArticleId><ArticleId IdType="pmc">PMC8763445</ArticleId><ArticleId IdType="pubmed">35039987</ArticleId></ArticleIdList></Reference><Reference><Citation>Essajee F, Lishman J, Solomons R, Abraham DR, Goussard P, Toorn RV. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection. BMJ Case Rep. 2021;14:e244102. doi: 10.1136/bcr-2021-244102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244102</ArticleId><ArticleId IdType="pmc">PMC8359482</ArticleId><ArticleId IdType="pubmed">34380685</ArticleId></ArticleIdList></Reference><Reference><Citation>Galassi G, Marchioni A. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay. Acta Neurol Belg. 2021;121:633&#x2013;42. doi: 10.1007/s13760-021-01612-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01612-6</ArticleId><ArticleId IdType="pmc">PMC8018746</ArticleId><ArticleId IdType="pubmed">33811309</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SMI, Yasmin F, Memon RS, Jatoi NN, Savul IS, Kazmi S, et al. COVID-19 and myasthenia gravis: a review of neurological implications of the SARS-COV-2. Brain Behav. 2022;12:e2789. doi: 10.1002/brb3.2789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2789</ArticleId><ArticleId IdType="pmc">PMC9759145</ArticleId><ArticleId IdType="pubmed">36306401</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrih-Aknin S. Role of the thymus in autoimmune myasthenia gravis. Clin Exp Neuroimmunol. 2016;7:226&#x2013;37. doi: 10.1111/cen3.12319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen3.12319</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuvelier P, Roux H, Cou&#xeb;del-Courteille A, Dutrieux J, Naudin C, de Muylder BC, et al. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome. Crit Care. 2021;25:4. doi: 10.1186/s13054-020-03440-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03440-1</ArticleId><ArticleId IdType="pmc">PMC7781174</ArticleId><ArticleId IdType="pubmed">33397460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong CW, Luckey MA, Park JH. Intrathymic IL-7: the where, when, and why of IL-7 signaling during T&#xa0;cell development. Semin Immunol. 2012;24:151&#x2013;8. doi: 10.1016/j.smim.2012.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2012.02.002</ArticleId><ArticleId IdType="pmc">PMC3358706</ArticleId><ArticleId IdType="pubmed">22421571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe9; G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, et al. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French rare health care for neuromuscular diseases network. Rev Neurol. 2020;176:507&#x2013;15. doi: 10.1016/j.neurol.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7167585</ArticleId><ArticleId IdType="pubmed">32354651</ArticleId></ArticleIdList></Reference><Reference><Citation>Varan O, Kucuk H, Tufan A. Myasthenia gravis due to hydroxychloroquine. Reumatismo. 2016;67:125. doi: 10.4081/reumatismo.2015.849.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/reumatismo.2015.849</ArticleId><ArticleId IdType="pubmed">26876193</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, et al. Graves&#x2019; disease. Nat Rev Dis Primer. 2020;6:52. doi: 10.53347/rid-78796.</Citation><ArticleIdList><ArticleId IdType="doi">10.53347/rid-78796</ArticleId><ArticleId IdType="pubmed">32616746</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzolla G, Marcocci C, Marin&#xf2; M. Graves&#x2019; disease and Graves&#x2019; orbitopathy following COVID-19. J Endocrinol Invest. 2021;44:2011&#x2013;2. doi: 10.1007/s40618-021-01576-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01576-7</ArticleId><ArticleId IdType="pmc">PMC8106371</ArticleId><ArticleId IdType="pubmed">33964007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves&#x2019; disease after COVID-19. J Endocrinol Invest. 2020;43:1527&#x2013;8. doi: 10.1007/s40618-020-01366-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01366-7</ArticleId><ArticleId IdType="pmc">PMC7368923</ArticleId><ArticleId IdType="pubmed">32686042</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: report of Hashimoto thyroiditis, Graves&#x2019; disease, and subacute thyroiditis. J Clin Transl Endocrinol Case Rep. 2021;22:100094. doi: 10.1016/j.jecr.2021.100094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jecr.2021.100094</ArticleId><ArticleId IdType="pmc">PMC8387132</ArticleId><ArticleId IdType="pubmed">34462717</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards K, Hussain I. Two cases of severe autoimmune thyrotoxicosis following SARS-CoV-2 infection. J Investig Med High Impact Case Rep. 2021;9 doi: 10.1177/23247096211056497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23247096211056497</ArticleId><ArticleId IdType="pmc">PMC8640318</ArticleId><ArticleId IdType="pubmed">34844465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockett J, Nelson C, Pierce R, Morlan AV. A case report of Graves&#x2019; disease following SARS-CoV-2 infection. Int J Contemp Pediatr. 2021;8:1260&#x2013;3. doi: 10.18203/2349-3291.ijcp20212481.</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2349-3291.ijcp20212481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nham E, Song E, Hyun H, Seong H, Yoon JG, Noh JY, et al. Concurrent subacute thyroiditis and Graves&#x2019; disease after COVID-19: a case report. J Korean Med Sci. 2023;38:e134. doi: 10.3346/jkms.2023.38.e134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e134</ArticleId><ArticleId IdType="pmc">PMC10166700</ArticleId><ArticleId IdType="pubmed">37158771</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;a &#xc2;S, Pinto SM, Vieira DC, Silva MT, Pinho PL. Graves disease: a new association with COVID-19? Semergen. 2023;49:101834. doi: 10.1016/j.semerg.2022.101834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semerg.2022.101834</ArticleId><ArticleId IdType="pmc">PMC9424509</ArticleId><ArticleId IdType="pubmed">36183480</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle DC, Mullally JA. Thyrotoxicosis after COVID-19 infection with a delay in Graves&#x2019; disease antibody positivity. Case Rep Endocrinol. 2023;2023:8402725. doi: 10.1155/2023/8402725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/8402725</ArticleId><ArticleId IdType="pmc">PMC10118873</ArticleId><ArticleId IdType="pubmed">37089262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayar I, Tahri S, Hajji E, Amor BB, Sayadi H, Marmouch H, et al. A case of Grave&#x2019;s disease following SARS-Cov 2 infection. Endocr Abstr. 2021;73:AEP657. doi: 10.1530/endoabs.73.aep657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/endoabs.73.aep657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghareebian H, Mariash C. COVID-19-Induced Graves&#x2019; disease. Cureus. 2022;14:e22260. doi: 10.7759/cureus.22260.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.22260</ArticleId><ArticleId IdType="pmc">PMC8931151</ArticleId><ArticleId IdType="pubmed">35340481</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanovych A, Laniush F, Borovets M, Kozlovska K. Coronavirus as a trigger of Graves&#x2019; disease. Acta Endocrinol Buchar. 2021;17:413&#x2013;5. doi: 10.4183/aeb.2021.413.</Citation><ArticleIdList><ArticleId IdType="doi">10.4183/aeb.2021.413</ArticleId><ArticleId IdType="pmc">PMC8919476</ArticleId><ArticleId IdType="pubmed">35342470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa B, Santos CP, Ferreira AG, Judas T. Graves&#x2019; disease caused by SARS-CoV-2 infection. Eur J Case Rep Intern Med. 2022;9:003470. doi: 10.12890/2022_003470.</Citation><ArticleIdList><ArticleId IdType="doi">10.12890/2022_003470</ArticleId><ArticleId IdType="pmc">PMC9426958</ArticleId><ArticleId IdType="pubmed">36051161</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9:45. doi: 10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Duntas LH, Jonklaas J. COVID-19 and thyroid diseases: a bidirectional impact. J Endocr Soc. 2021;5:bvab076. doi: 10.1210/jendso/bvab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab076</ArticleId><ArticleId IdType="pmc">PMC8135350</ArticleId><ArticleId IdType="pubmed">34189381</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183:381&#x2013;7. doi: 10.1530/eje-20-0335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group , Mur I, Mateo GM, Gutierrez MM, Pomar V, de Benito N, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499&#x2013;518. doi: 10.1001/jama.2021.11330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11330</ArticleId><ArticleId IdType="pmc">PMC8261689</ArticleId><ArticleId IdType="pubmed">34228774</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentsen S, Barcellini W. Autoimmune hemolytic anemias. N Engl J Med. 2021;385:1407&#x2013;19. doi: 10.1056/nejmra2033982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmra2033982</ArticleId><ArticleId IdType="pubmed">34614331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020;190:29&#x2013;31. doi: 10.1111/bjh.16794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16794</ArticleId><ArticleId IdType="pmc">PMC7267601</ArticleId><ArticleId IdType="pubmed">32374906</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Cabrera G, Mendez-Garcia E, Mora-Torres M, Campos-Cabrera S, Campos-Cabrera V, Garcia-Rubio G, et al. Autoimmune hemolytic anemia as initial presentation of COVID-19 infection. Blood. 2020;136:8. doi: 10.1182/blood-2020-139001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2020-139001</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Capes A, Bailly S, Hantson P, Gerard L, Laterre PF. COVID-19 infection associated with autoimmune hemolytic anemia. Ann Hematol. 2020;99:1679&#x2013;80. doi: 10.1007/s00277-020-04137-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04137-9</ArticleId><ArticleId IdType="pmc">PMC7295688</ArticleId><ArticleId IdType="pubmed">32542444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K. Severe autoimmune hemolytic anemia in COVID-19 infection, safely treated with steroids. Mediterr J Hematol Infect Dis. 2020;12:e2020053. doi: 10.4084/mjhid.2020.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/mjhid.2020.053</ArticleId><ArticleId IdType="pmc">PMC7340241</ArticleId><ArticleId IdType="pubmed">32670531</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh TC, Sostin O. Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids. Ann Hematol. 2022;101:431&#x2013;2. doi: 10.1007/s00277-021-04457-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-021-04457-4</ArticleId><ArticleId IdType="pmc">PMC7891115</ArticleId><ArticleId IdType="pubmed">33604688</ArticleId></ArticleIdList></Reference><Reference><Citation>Huda Z, Jahangir A, Sahra S, Niazi MRK, Anwar S, Glaser A, et al. A case of COVID-19-associated autoimmune hemolytic anemia with hyperferritinemia in an immunocompetent host. Cureus. 2021;13:e16078. doi: 10.7759/cureus.16078.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.16078</ArticleId><ArticleId IdType="pmc">PMC8324606</ArticleId><ArticleId IdType="pubmed">34345558</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J, Eichbaum Q. COVID-19 associated with severe autoimmune hemolytic anemia. Transfusion. 2021;61:635&#x2013;40. doi: 10.1111/trf.16226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16226</ArticleId><ArticleId IdType="pmc">PMC7753740</ArticleId><ArticleId IdType="pubmed">33274459</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawed M, Hart E, Saeed M. Haemolytic anaemia: a consequence of COVID-19. BMJ Case Rep. 2020;13:e238118. doi: 10.1136/bcr-2020-238118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-238118</ArticleId><ArticleId IdType="pmc">PMC10577752</ArticleId><ArticleId IdType="pubmed">33303503</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Nguyen CB, Yeung Z, Sanchez K, Rosen D, Bushan S. Evans syndrome in a patient with COVID-19. Br J Haematol. 2020;190:e59&#x2013;61. doi: 10.1111/bjh.16846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16846</ArticleId><ArticleId IdType="pmc">PMC7276874</ArticleId><ArticleId IdType="pubmed">32420629</ArticleId></ArticleIdList></Reference><Reference><Citation>Liput JR, Jordan K, Patadia R, Kander E. Warm autoimmune hemolytic anemia associated with asymptomatic SARS-CoV-2 infection. Cureus. 2021;13:e14101. doi: 10.7759/cureus.14101.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.14101</ArticleId><ArticleId IdType="pmc">PMC8075761</ArticleId><ArticleId IdType="pubmed">33927918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia. Br J Haematol. 2020;190:31&#x2013;2. doi: 10.1111/bjh.16786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16786</ArticleId><ArticleId IdType="pmc">PMC7267644</ArticleId><ArticleId IdType="pubmed">32369626</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil NR, Herc ES, Girgis M. Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol Oncol Stem Cell Ther. 2022;15:8. doi: 10.1016/j.hemonc.2020.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hemonc.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7336954</ArticleId><ArticleId IdType="pubmed">32645300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Ruperto L, Garc&#xed;a-P&#xe9;rez E, Hern&#xe1;ndez-Maraver D, Kerguel&#xe9;n-Fuentes A, Viejo-Llorente A, Robles-Marhuenda &#xc1;, et al. A 3-case series of autoimmune haemolytic anaemia and COVID-19: is plasma exchange an alternative? SN Compr Clin Med. 2021;3:1420&#x2013;3. doi: 10.1007/s42399-021-00884-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00884-6</ArticleId><ArticleId IdType="pmc">PMC8043757</ArticleId><ArticleId IdType="pubmed">33870092</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagorski E, Pawar T, Rahimian S, Forman D. Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19) Br J Haematol. 2020;190:e183&#x2013;4. doi: 10.1111/bjh.16892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16892</ArticleId><ArticleId IdType="pmc">PMC7283683</ArticleId><ArticleId IdType="pubmed">32460350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshmi JN, Aravind R. COVID-19-Associated severe autoimmune hemolytic anemia: a rare case report. Saudi J Med Med Sci. 2021;9:276&#x2013;9. doi: 10.4103/sjmms.sjmms_203_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sjmms.sjmms_203_21</ArticleId><ArticleId IdType="pmc">PMC8474002</ArticleId><ArticleId IdType="pubmed">34667477</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonla C, Watanaboonyongcharoen P, Suwanpimolkul G, Paitoonpong L, Jantarabenjakul W, Chanswangphuwana C, et al. Cold agglutinin disease following SARS-CoV-2 and Mycoplasma pneumoniae co-infections. Clin Case Rep. 2020;8:2402&#x2013;5. doi: 10.1002/ccr3.3152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3152</ArticleId><ArticleId IdType="pmc">PMC7404354</ArticleId><ArticleId IdType="pubmed">32837721</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslov DV, Simenson V, Jain S, Badari A. COVID-19 and cold agglutinin hemolytic anemia. TH Open. 2020;04:e175&#x2013;7. doi: 10.1055/s-0040-1715791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715791</ArticleId><ArticleId IdType="pmc">PMC7440967</ArticleId><ArticleId IdType="pubmed">32844144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur J, Mogulla S, Khan R, Krishnamoorthy G, Garg S. Transient cold agglutinins in a patient with COVID-19. Cureus. 2021;13:e12751. doi: 10.7759/cureus.12751.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12751</ArticleId><ArticleId IdType="pmc">PMC7885958</ArticleId><ArticleId IdType="pubmed">33643726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen CE, Wilson S, Thombare A, Weiss S, Ma A. Cold agglutinin syndrome as a complication of Covid-19 in two cases. Clin Infect Pract. 2020;7&#x2013;8:100041. doi: 10.1016/j.clinpr.2020.100041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinpr.2020.100041</ArticleId><ArticleId IdType="pmc">PMC7480768</ArticleId><ArticleId IdType="pubmed">32924007</ArticleId></ArticleIdList></Reference><Reference><Citation>Huscenot T, Galland J, Ouvrat M, Rossignol M, Mouly S, S&#xe8;ne D. SARS-CoV-2-associated cold agglutinin disease: a report of two cases. Ann Hematol. 2020;99:1943&#x2013;4. doi: 10.1007/s00277-020-04129-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04129-9</ArticleId><ArticleId IdType="pmc">PMC7317069</ArticleId><ArticleId IdType="pubmed">32591877</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldaghlawi F, Shammah A, Kio E. SARS-CoV-2 infection complicated with cold agglutinin disease and myositis. Clin Case Rep. 2021;9:2196&#x2013;9. doi: 10.1002/ccr3.3981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3981</ArticleId><ArticleId IdType="pmc">PMC8077249</ArticleId><ArticleId IdType="pubmed">33936663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesr G, Koshy R, Foldes D, Kagdi H. Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-na&#xef;ve chronic lymphocytic leukaemia: a case report. Br J Haematol. 2020;190:e326&#x2013;8. doi: 10.1111/bjh.17079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17079</ArticleId><ArticleId IdType="pubmed">33460041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sujana IPS, Widiasari NPA, Arisanti NLPE, Rai IBN, Rena NMRA. Autoimmune hemolytic anemia as a novel complication of COVID-19 infection in Sanglah General Hospital Bali, Indonesia. Open Access Maced J Med Sci. 2020;8:509&#x2013;13. doi: 10.3889/oamjms.2020.5484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3889/oamjms.2020.5484</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghuwanshi B. Serological blood group discrepancy and cold agglutinin autoimmune hemolytic anemia associated with novel coronavirus. Cureus. 2020;12:e11495. doi: 10.7759/cureus.11495.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11495</ArticleId><ArticleId IdType="pmc">PMC7744217</ArticleId><ArticleId IdType="pubmed">33354441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelle MC, Tassone B, Ricchio M, Mazzitelli M, Davoli C, Procopio G, et al. Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report. J Med Case Rep. 2020;14:246. doi: 10.1186/s13256-020-02595-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-020-02595-3</ArticleId><ArticleId IdType="pmc">PMC7746982</ArticleId><ArticleId IdType="pubmed">33339534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mausoleo A, Henriquez S, Goujard C, Roque-Afonso AM, Noel N, Lambotte O. Severe IgA-mediated autoimmune hemolytic anemia triggered by SARS-CoV-2 infection. Leuk Lymphom. 2021;62:2037&#x2013;9. doi: 10.1080/10428194.2021.1888378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10428194.2021.1888378</ArticleId><ArticleId IdType="pubmed">33618609</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifeh HK, Mourad YM, Chamoun CT. Infantile cytomegalovirus-associated severe warm autoimmune hemolytic anemia: a case report. Children. 2017;4:94. doi: 10.3390/children4110094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children4110094</ArticleId><ArticleId IdType="pmc">PMC5704128</ArticleId><ArticleId IdType="pubmed">29099741</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandale OA, Jumah H, Jamil H. Hepatitis A virus infection is complicated by both pancytopenia and autoimmune hemolytic anemia (AIHA) Ann Med Surg. 2022;78:103765. doi: 10.1016/j.amsu.2022.103765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103765</ArticleId><ArticleId IdType="pmc">PMC9118502</ArticleId><ArticleId IdType="pubmed">35600174</ArticleId></ArticleIdList></Reference><Reference><Citation>Angileri F, L&#xe9;gar&#xe9; S, Gammazza AM, de Macario EC, Macario AJL, Cappello F. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? Br J Haematol. 2020;190:e92&#x2013;3. doi: 10.1111/bjh.16883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16883</ArticleId><ArticleId IdType="pmc">PMC7283741</ArticleId><ArticleId IdType="pubmed">32453861</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv. 2021</Citation></Reference><Reference><Citation>Lam LKM, Reilly JP, Rux AH, Murphy SJ, Kuri-Cervantes L, Weisman AR, et al. Erythrocytes identify complement activation in patients with COVID-19. Am J Physiol Lung Cell Mol Physiol. 2021;321:L485&#x2013;9. doi: 10.1152/ajplung.00231.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00231.2021</ArticleId><ArticleId IdType="pmc">PMC8384475</ArticleId><ArticleId IdType="pubmed">34231390</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4:43. doi: 10.1176/appi.books.9781615372423.sy18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.books.9781615372423.sy18</ArticleId><ArticleId IdType="pubmed">30410033</ArticleId></ArticleIdList></Reference><Reference><Citation>Palao M, Fernandez-D&#xed;az E, Gracia-Gil J, Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020;45:102377. doi: 10.1016/j.msard.2020.102377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102377</ArticleId><ArticleId IdType="pmc">PMC7340057</ArticleId><ArticleId IdType="pubmed">32698095</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragoso YD, Pacheco FAS, Silveira GL, Oliveira RA, Carvalho VM, Martimbianco ALC. COVID-19 in a temporal relation to the onset of multiple sclerosis. Mult Scler Relat Disord. 2021;50:102863. doi: 10.1016/j.msard.2021.102863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.102863</ArticleId><ArticleId IdType="pmc">PMC7902206</ArticleId><ArticleId IdType="pubmed">33662859</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsidag S, Sahin S, Ates MF, Cinar N, Kendirli S. Demyelinating disease of the central nervous system concurrent with COVID-19. Cureus. 2021;13:e17297. doi: 10.7759/cureus.17297.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.17297</ArticleId><ArticleId IdType="pmc">PMC8449512</ArticleId><ArticleId IdType="pubmed">34552833</ArticleId></ArticleIdList></Reference><Reference><Citation>Florea AA, Sirbu CA, Ghinescu MC, Plesa CF, Sirbu AM, Mitrica M, et al. SARS-CoV-2, multiple sclerosis, and focal deficit in a postpartum woman: a case report. Exp Ther Med. 2021;21:92. doi: 10.3892/etm.2020.9524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.9524</ArticleId><ArticleId IdType="pmc">PMC7725028</ArticleId><ArticleId IdType="pubmed">33363603</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghajanian S, Shafiee A, Akhondi A, Abadi SRF, Mohammadi I, Ehsan M, et al. The effect of COVID-19 on multiple sclerosis relapse: a systematic review and meta-analysis. Mult Scler Relat Disord. 2024;81:105128. doi: 10.1016/j.msard.2023.105128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2023.105128</ArticleId><ArticleId IdType="pubmed">37979408</ArticleId></ArticleIdList></Reference><Reference><Citation>Houtman JJ, Fleming JO. Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol. 1996;2:361&#x2013;76. doi: 10.3109/13550289609146902.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13550289609146902</ArticleId><ArticleId IdType="pubmed">8972418</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Yang Y, Gao J. Infectivity of human coronavirus in the brain. EBioMedicine. 2020;56:102799. doi: 10.1016/j.ebiom.2020.102799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102799</ArticleId><ArticleId IdType="pmc">PMC7255711</ArticleId><ArticleId IdType="pubmed">32474399</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarin C, Bergmann CC. Viral-induced suppression of self-reactive T&#xa0;cells: lessons from neurotropic coronavirus-induced demyelination. J Neuroimmunol. 2017;308:12&#x2013;6. doi: 10.1016/j.jneuroim.2017.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.01.003</ArticleId><ArticleId IdType="pmc">PMC5474352</ArticleId><ArticleId IdType="pubmed">28108025</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3:e324&#x2013;5. doi: 10.1016/s2665-9913(21)00067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2665-9913(21)00067-9</ArticleId><ArticleId IdType="pmc">PMC7963449</ArticleId><ArticleId IdType="pubmed">33748780</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Santas M, Diaz-Guimaraens B, Abellas PG, del Real CMG, Burgos-Blasco P, Suarez-Valle A. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) J Eur Acad Dermatol Venereol. 2020;34:e536&#x2013;7. doi: 10.1111/jdv.16663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16663</ArticleId><ArticleId IdType="pmc">PMC7283648</ArticleId><ArticleId IdType="pubmed">32453865</ArticleId></ArticleIdList></Reference><Reference><Citation>Anindya R, Rutter GA, Meur G. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection. Immunol Cell Biol. 2023;101:191&#x2013;203. doi: 10.1111/imcb.12615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12615</ArticleId><ArticleId IdType="pmc">PMC9877852</ArticleId><ArticleId IdType="pubmed">36529987</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes M, Nwachukwu I. GUILLAIN-BARR&#xc9; syndrome and hemolysis in COVID-19. Chest. 2021;160:A443. doi: 10.1016/j.chest.2021.07.436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.436</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. 2022;23:1716. doi: 10.3390/ijms23031716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D, Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res. 2020;68:310&#x2013;3. doi: 10.1007/s12026-020-09152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-020-09152-6</ArticleId><ArticleId IdType="pmc">PMC7499017</ArticleId><ArticleId IdType="pubmed">32946016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tough DF, Borrow P, Sprent J. Induction of bystander T&#xa0;cell proliferation by viruses and type I interferon in&#xa0;vivo . Science. 1996;272:1947&#x2013;50. doi: 10.1126/science.272.5270.1947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.272.5270.1947</ArticleId><ArticleId IdType="pubmed">8658169</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornaby C, Gibbons L, Mayhew V, Sloan CS, Welling A, Poole BD. B&#xa0;cell epitope spreading: mechanisms and contribution to autoimmune diseases. Immunol Lett. 2015;163:56&#x2013;68. doi: 10.1016/j.imlet.2014.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2014.11.001</ArticleId><ArticleId IdType="pubmed">25445494</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Gieseck C, Lipsk PE. Mechanisms of B&#xa0;cell autoimmunity in SLE. Arthritis Res Ther. 2011;13:243. doi: 10.1186/ar3433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3433</ArticleId><ArticleId IdType="pmc">PMC3308063</ArticleId><ArticleId IdType="pubmed">22078750</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Liu X, Chen X, li Q. Insights into new-onset autoimmune diseases after COVID-19 vaccination. Autoimmun Rev. 2023;22:103340. doi: 10.1016/j.autrev.2023.103340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103340</ArticleId><ArticleId IdType="pmc">PMC10108562</ArticleId><ArticleId IdType="pubmed">37075917</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;5:293. doi: 10.1038/s41392-020-00454-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00454-7</ArticleId><ArticleId IdType="pmc">PMC7758411</ArticleId><ArticleId IdType="pubmed">33361764</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SW, Ilyas I, Weng J. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther. 2020;5:128. doi: 10.1038/s41392-020-00243-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00243-2</ArticleId><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . Post COVID-19 condition (long COVID)  [August 24, 2023]. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition Available from: Accessed.</Citation></Reference><Reference><Citation>CDC  . Post-COVID conditions. 2023.  [24 August 2023]. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html Available from: Accessed.</Citation></Reference><Reference><Citation>Estefan&#xed;a E, Yang CL, Shannon CP, Assadian S, He D, Tebbutt SJ. Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Halim A, Halim M, Liu SL, Aljeldah M, Shammari BRA, et al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: a systematic review and meta-analysis of over 20 biomarkers. Rev Med Virol. 2023;33:e2424. doi: 10.1002/rmv.2424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;8. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;95. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulet A, Tarras&#xf3; J, Rodr&#xed;guez-Borja E, Carbonell-Asins JA, Lope-Mart&#xed;nez A, Mart&#xed;-Martinez A, et al. Biomarkers of fibrosis in patients with COVID-19 one year after hospital discharge: a prospective cohort study. Am J Respir Cell Mol Biol. 2023;69:321&#x2013;7. doi: 10.1165/rcmb.2022-0474oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2022-0474oc</ArticleId><ArticleId IdType="pmc">PMC10503307</ArticleId><ArticleId IdType="pubmed">36848314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;9. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat Methods. 2021;18:449&#x2013;53. doi: 10.1038/s41592-021-01145-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01145-z</ArticleId><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppkes M, Neurath MF. Rear window&#x2014;What can the gut tell us about long-COVID? Gastroenterology. 2022;163:376&#x2013;8. doi: 10.1053/j.gastro.2022.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.05.044</ArticleId><ArticleId IdType="pmc">PMC9175081</ArticleId><ArticleId IdType="pubmed">35660031</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing YH, Ni W, Wu Q, Li WJ, Li GJ, Wang WD, et al. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. J&#xa0;Microbiol Immunol Infect. 2020;53:473&#x2013;80. doi: 10.1016/j.jmii.2020.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.021</ArticleId><ArticleId IdType="pmc">PMC7141453</ArticleId><ArticleId IdType="pubmed">32276848</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;87.e9. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;63. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E, Achua J, Saltzman R, Khodamoradi K, Arora H, Ibrahim E, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J Mens Health. 2021;39:466&#x2013;9. doi: 10.5534/wjmh.210055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkeri R, Goebel S, Sharma GD. SARS-CoV-2 shedding from asymptomatic patients: contribution of potential extrapulmonary tissue reservoirs. Am J Trop Med Hyg. 2020;103:18&#x2013;21. doi: 10.4269/ajtmh.20-0279.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0279</ArticleId><ArticleId IdType="pmc">PMC7356473</ArticleId><ArticleId IdType="pubmed">32406369</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76:487&#x2013;90. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights into SARS-CoV-2 persistence and its relevance. Viruse. 2021;13:1025. doi: 10.3390/v13061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061025</ArticleId><ArticleId IdType="pmc">PMC8228265</ArticleId><ArticleId IdType="pubmed">34072390</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19. J Med Virol. 2021;93:1850&#x2013;1. doi: 10.1002/jmv.26549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26549</ArticleId><ArticleId IdType="pmc">PMC7537064</ArticleId><ArticleId IdType="pubmed">32970319</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, Kalioubie AE, et al. High incidence of Epstein&#x2013;Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021;51:296&#x2013;9. doi: 10.1016/j.idnow.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7816954</ArticleId><ArticleId IdType="pubmed">33495765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehner GF, Klein SJ, Zoller H, Peer A, Bellmann R, Joannidis M. Correlation of interleukin-6 with Epstein&#x2013;Barr virus levels in COVID-19. Crit Care. 2020;24:657. doi: 10.1186/s13054-020-03384-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03384-6</ArticleId><ArticleId IdType="pmc">PMC7682685</ArticleId><ArticleId IdType="pubmed">33228750</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133:e163669. doi: 10.1172/jci163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022;42:1523&#x2013;30. doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, RECOVER Mechanistic Pathways Task Force Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12:e86015. doi: 10.7554/elife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J&#xa0;Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y, Ryabkova VA, Scheibenbogen C, Brinth L, Martinez-Lavin M, Ikeda S, et al. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol. 2020;214:108384. doi: 10.1016/j.clim.2020.108384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108384</ArticleId><ArticleId IdType="pubmed">32171889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, et al. Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C, Mardin C, Lucio M, Wallukat G, Hoffmanns J, Schr&#xf6;der T, et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int J Mol Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;ngen HD, Dordevic A, Felix SB, Pieske B, Voors AA, McMurray JJV, et al. &#x3b2; 1-adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications. Circ Heart Fail. 2020;13:E006155. doi: 10.1161/circheartfailure.119.006155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circheartfailure.119.006155</ArticleId><ArticleId IdType="pubmed">31957469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingel H, Meltendorf S, Billing U, Thurm C, Vogel K, Majer C, et al. Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J Autoimmun. 2021;122:102682. doi: 10.1016/j.jaut.2021.102682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102682</ArticleId><ArticleId IdType="pmc">PMC8214939</ArticleId><ArticleId IdType="pubmed">34214763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ECY, Tyler RE, Johnson D, Koh N, Ong BC, Foo SY, et al. High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples. J Mol Cell Cardiol. 2022;170:121&#x2013;3. doi: 10.1016/j.yjmcc.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2022.06.006</ArticleId><ArticleId IdType="pmc">PMC9233549</ArticleId><ArticleId IdType="pubmed">35764120</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53:19&#x2013;25. doi: 10.1016/j.immuni.2020.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7321048</ArticleId><ArticleId IdType="pubmed">32610079</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodr&#xed;guez Y, Zapata E, Ram&#xed;rez-Santana C, et al. Persistent autoimmune activation and proinflammatory state in post-COVID syndrome. J Infect Dis. 2022;225:2155&#x2013;62. doi: 10.1093/infdis/jiac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez L, Tan ZY, Lakshmikanth T, Wang J, Barcenilla H, Gonzalez L, et al. Immune system perturbations in patients with severe long COVID. J Immunol. 2023;210:233.07. doi: 10.4049/jimmunol.210.supp.233.07.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.210.supp.233.07</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250&#x2013;6. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin DD. Is long COVID an autoimmune disease? Eur Respir J. 2023;61:2202272. doi: 10.1183/13993003.02272-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02272-2022</ArticleId><ArticleId IdType="pubmed">36634924</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E, Yang CL, Shannon CP, Assadian S, He D, Tebbutt SJ. Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;53. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19:1064&#x2013;70. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan BE, Wong SW, Sum CLL, Lim GH, Leung BP, Tan CW, et al. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: assessing the long-term outcomes in COVID-19 patients. Am J Hematol. 2022;97:915&#x2013;23. doi: 10.1002/ajh.26575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing HJ, Wu XM, Xiang MQ, Liu LJ, Liu VA, Shi JL. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front Immunol. 2022;13:992384. doi: 10.3389/fimmu.2022.992384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.992384</ArticleId><ArticleId IdType="pmc">PMC9709252</ArticleId><ArticleId IdType="pubmed">36466841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy. 2022;77:1288&#x2013;91. doi: 10.1111/all.15188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors. 2020;46:306&#x2013;8. doi: 10.1002/biof.1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1633</ArticleId><ArticleId IdType="pmc">PMC7267424</ArticleId><ArticleId IdType="pubmed">32339387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, et al. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020;26:402&#x2013;14. doi: 10.1177/1073858420941476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420941476</ArticleId><ArticleId IdType="pubmed">32684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun S, Storan A, Myers B. Mast cell activation syndrome and the link with long COVID. Br J Hosp Med. 2022;83:1&#x2013;10. doi: 10.12968/hmed.2022.0123.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2022.0123</ArticleId><ArticleId IdType="pubmed">35938771</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in long-COVID. Int J Infect Dis. 2021;112:217&#x2013;26. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;32. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Su Q, Zhang F, Tun HM, Mak JWY, Lui GCY, et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat Commun. 2022;13:6806. doi: 10.1038/s41467-022-34535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharbi KS, Singh Y, Almalki WH, Rawat S, Afzal O, Altamimi ASA, et al. Gut microbiota disruption in COVID-19 or post-COVID illness association with severity biomarkers: a possible role of pre/pro-biotics in manipulating microflora. Chem Biol Interact. 2022;358:109898. doi: 10.1016/j.cbi.2022.109898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2022.109898</ArticleId><ArticleId IdType="pmc">PMC8934739</ArticleId><ArticleId IdType="pubmed">35331679</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GCY, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;52. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein&#x2013;Barr virus and the gut&#x2013;brain axis. Mol Psychiatry. 2023;28:4968&#x2013;76. doi: 10.1038/s41380-023-02161-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02161-5</ArticleId><ArticleId IdType="pmc">PMC11041741</ArticleId><ArticleId IdType="pubmed">37402856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM, et al. Plasticity of TH17 cells in Peyer&#x2019;s patches is responsible for the induction of T&#xa0;cell&#x2013;dependent IgA responses. Nat Immunol. 2013;14:372&#x2013;9. doi: 10.1038/ni.2552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2552</ArticleId><ArticleId IdType="pmc">PMC3672955</ArticleId><ArticleId IdType="pubmed">23475182</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2007;2:328&#x2013;39. doi: 10.1016/j.chom.2007.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.09.013</ArticleId><ArticleId IdType="pubmed">18005754</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira-Ros&#xe1;rio A, Marques C, Pinheiro H, Ara&#xfa;jo JR, Ribeiro P, Rocha R, et al. Gut microbiota diversity and C-reactive protein are predictors of disease severity in COVID-19 patients. Front Microbiol. 2021;12:705020. doi: 10.3389/fmicb.2021.705020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.705020</ArticleId><ArticleId IdType="pmc">PMC8326578</ArticleId><ArticleId IdType="pubmed">34349747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479:537&#x2013;59. doi: 10.1042/bcj20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bcj20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Majolo F, Silva GL, Vieira L, Anli C, Timmers LFSM, Laufer S, et al. Neuropsychiatric disorders and COVID-19: what we know so far. Pharmaceuticals. 2021;14:933. doi: 10.3390/ph14090933.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14090933</ArticleId><ArticleId IdType="pmc">PMC8465079</ArticleId><ArticleId IdType="pubmed">34577633</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28:2406&#x2013;15. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol-Neuroimmunol Neuroinflammation. 2022;9:e1146. doi: 10.1212/nxi.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;68. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;9. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;8. doi: 10.1016/s0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. 2020;130:3950&#x2013;3. doi: 10.1172/jci140183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci140183</ArticleId><ArticleId IdType="pmc">PMC7410042</ArticleId><ArticleId IdType="pubmed">32459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic long&#x2010;COVID syndrome: a protracted COVID&#x2010;19 illness with neurological dysfunctions. CNS Neurosci Ther. 2021;27:1433&#x2013;6. doi: 10.1111/cns.13737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13737</ArticleId><ArticleId IdType="pmc">PMC8611765</ArticleId><ArticleId IdType="pubmed">34626096</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321&#x2013;44. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23:618&#x2013;34. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss JI. Long haul COVID 19 is the result of B lymphocyte anergy reversal. Mod Appl Pharm Pharmacol. 2023;3</Citation></Reference><Reference><Citation>Scholkmann F, May CA. COVID-19, post-acute COVID-19 syndrome (PACS, &#x201c;long COVID&#x201d;) and post-COVID-19 vaccination syndrome (PCVS, &#x201c;post-COVIDvac-syndrome&#x201d;): similarities and differences. Pathol Res Pract. 2023;246:154497. doi: 10.1016/j.prp.2023.154497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2023.154497</ArticleId><ArticleId IdType="pmc">PMC10154064</ArticleId><ArticleId IdType="pubmed">37192595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long Covid symptoms after Covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long COVID? Lancet Respir Med. 2022;10:e30. doi: 10.1016/s2213-2600(22)00020-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00020-0</ArticleId><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>